chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen and tender to touch lymph node in right armpit.   Persistent and at times severe headache.   Nausea and dizziness.  Right arm is sore at injection site.
First vaccine with only sore arm. Second vaccine on a Wednesday with flu like symptoms starting that night and by Friday noon was over them. Friday afternoon my arm is painful and red, hot and hurting. Today is Saturday and it is still painful and hot- red. Large area.
Severe fatigue, headache,  body aches. Fatigue and muscle aches lasted 36 hours. Headache is lingering at the 36 hour mark.
Pt vax; devel large area of erythema, swelling, warmth  tenderness at inject site.  Sx subsided over 3 days.  Vax given after superficial laceration.
fast heart beat (102), raised blood pressure (175/105)  6:00 pm to 12:00 am.  Stayed in emergency room for observation till numbers decreased.  Palpitations as diagnosis. Released aprox 12:30 am.
Red itchy skin that started on arms. It advanced to raised bumps on arms and torso and upper thighs.  It began on 3/19/2021 and he still has residual redness and itchiness, although it has receded a bit, as of 4/15/2021
BLOOD CLOTS IN THE LUNGS; BLOOD CLOTS IN THE HEART; This spontaneous report received from a consumer via social media concerned multiple patients of unspecified age, sex, race and ethnicity. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The dose number in series was 1. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced "blood clots in the lungs, and blood clots in the heart". On an unspecified date, the patient died from "blood clots in the lungs, and blood clots in the heart". It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots in the lungs, and blood clots in the heart was fatal. This report was serious (Death).; Sender's Comments: V0:  20211222177-covid-19 vaccine ad26.cov2.s-blood clots in the lungs, and blood clots in the heart. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: BLOOD CLOTS IN THE LUNGS; BLOOD CLOTS IN THE HEART
Had fever after first shot. Body ache, headache and muscle pain after 2nd shot. No period since then . Last period was on January 18th, 2021. Period abruptly stopped
Pfizer-BioNTech COVID-19 Vaccine: Approximately 90 minutes after receiving vaccine patient returned to clinic reporting dizziness, flushing, nausea, claminess, and hot flashes. Initial blood pressure 133/97 mmHg, other vital signs reported as stable. Patient provided with ice pack, water, and snack. Patient was observed for one hour and symptoms improved. No loss of consciousness or respiratory symptoms reported. Patient left clinic stable.
Severe fever, severe chills to the point I couldn't get out of bed cause I would start shaking so bad, head aches, body aches, fatigue
Information has been received from a registered nurse concerning a 26 year old male with controlled asthma. On 18 SEPT 2000, serum varicella zoster virus antibody test indicated the patient was "non-immune". On 05 OCT 2000, he was vaccinated SC in the left arm with a first dose of varicella virus vaccine live (lot # 632369/1461J). Concomitant therapy on 05 OCT 2000 included a first dose SC in the right arm of measles virus vaccine live (MSD) (lot #627545/0624K). On 02 NOV 2000, he was vaccinated SC in the left arm with a second dose of varicella virus vaccine live (lot #632369/1461J). Concomitant therapy on 02 NOV 2000 included a first dose IM in the right deltoid of hepatitis B vaccine (ENGERIX-B) (lot #ENG3223A2). The registered nurse reported that the patient had been analyzed for response, and the patient had failed to initially seroconvert. On 18 DEC 2000 serum varicella zoster virus antibody test was reported as equivoc. On 26 JAN 2001 and 21 FEB 2001 the patient was vaccinated SC in the left arm with a third and fourth dose of varicella virus vaccine live (lot #636571/0928K). The patient again failed to seroconvert. On 29 MAY 2001 serum varicella zoster virus antibody test was reported as equivoc. The patient had sought unspecified medical attention. Additional information is not expected.
Patient reports to clinic on this date (03/21/2015) and reports prolonged swelling of lymph nodes under L) armpit and tenderness. Patient reports pain scale 5/10. Patient evaluated by Dr. on this date. Patient instructed to return to clinic for follow-up evaluation on 3/23/2015 to R/O abscess. Patient also prescribed Doxycycline 100mg.
On the day after my second vaccine I woke up with a hard nodule about the size of a marble and it itched.  As the weed went on it grew and after six days it was 2 1/2 by 3 1/2 inches in size.  It then resolved itself
hypertension; tired; Headache; This is a spontaneous report from contactable nurse, the patient.  A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EK5730), via an unspecified route of administration on 19Dec2020 as a single dose for COVID-19 immunization.  Ongoing medical history included hypothyroidism. Other relevant medical history included anxiety and menopause.  Ongoing concomitant medications included estradiol (MANUFACTURER UNKNOWN) taken for menopause, progesterone (MANUFACTURER UNKNOWN) taken for menopause, and venlafaxine hydrochloride (EFFEXOR) taken for anxiety.  On 19Dec2020 at 18:00, the patient had a headache. On 20Dec2020, the patient experienced hypertension and was tired. The clinical course was as follows: the patient received her vaccine on 19Dec2020. At 18:00 on 19Dec2020, she started with a headache, and it was not a big deal. In the morning of 20Dec2020, her headache was bad, and then her blood pressure was 180/100. She had a headache and she was tired. She mentioned her baseline was 115/84. She had no coffee or anything, and as the day went by it was 140/90. She reported that the hypertension basically lasted for one day and in the morning of 21Dec2020 it was 120/88. As of 21Dec2020, she did not have a headache. The clinical outcomes of the hypertension and headache were recovered on unknown dates in Dec2020; while that of the tiredness was unknown. The patient assessed the hypertension and headache as serious for being medically significant and related to the vaccine; however, the seriousness and causality assessment were not provided for the tiredness.; Sender's Comments: A causal association between BNT162B2 and the events hypertension and headache cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
Right arm rash appeared a week after vaccination, the size of an Avocado with a quarter size rash beneath it. Very itchy and warm to touch. Headache and tired for 2 days.
Brain swelling; Swelling of fingers; Ear swelling; Leg injury; Fall; This is a solicited report based on the information received by Pfizer  Control No.:21K-163-3887651-00. A contactable consumer (patient) and a physician reported that a 61 years old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 intramuscularly on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 Vaccination; adalimumab (HUMIRA, Solution for injection in pre-filled pen), subcutaneously from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at unknown dose and frequency (Citrate Free) for psoriatic arthritis.  The patient's medical history and concomitant medications was not reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Patient experienced swelling in ears, head and fingers; fall/was on crutches due to hurt leg after fall, all on an unknown date. The patient was treated with BENADRYL. The outcome of fall was recovering. The outcome of other events was unknown. Causality for HUMIRA(ADALIMUMAB) was not provided.  The reporter's assessment of the causal relationship of the events with the suspect product bnt162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  Information about Lot/Batch number cannot be obtained. Additional information has been requested.; Sender's Comments: Based on the information currently available,vaccine BNT162B2 or comirnarity is unrelated to the event brain edema.. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Woke up in the morning about 7:45 with a terrible Headache that lasted for about 3 hours and returned again about 5pm for about 1hr.  My body felt exhausted, tired and drained the entire day. I was also extremely sleepy all day.  I experience muscle aching pain for about 1 hour starting about 4pm.  Also had pain on the arm that injection was given on.
I am experiencing lot of pain in my neck and my back, Between my shoulder blade.; I am experiencing lot of pain in my neck; lots of pain; drain into my throat; help with the muscles; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EW0165) at the age of 57 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Diabetes mellitus" (unspecified if ongoing), notes: Verbatim: Diabetes; "High Blood Pressure" (unspecified if ongoing), notes: Verbatim: High Blood Pressure; "Cancer" (unspecified if ongoing), notes: Verbatim: Cancer; "surgery related to cancer" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; METFORMIN; INSULIN; LASIX [FUROSEMIDE]; CALCIUM. The following information was reported: BACK PAIN (non-serious), outcome "unknown", described as "I am experiencing lot of pain in my neck and my back, Between my shoulder blade."; NECK PAIN (non-serious), outcome "unknown", described as "I am experiencing lot of pain in my neck"; PAIN (non-serious), outcome "unknown", described as "lots of pain"; OROPHARYNGEAL DISCOMFORT (non-serious), outcome "unknown", described as "drain into my throat"; MUSCLE DISORDER (non-serious), outcome "unknown", described as "help with the muscles". Therapeutic measures were taken as a result of oropharyngeal discomfort, muscle disorder.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Lab tests were done on Thursday. Treatment included taking Flonase for the drain into my throat and took some ibuprofen to help with the muscles.  No follow-up attempts are possible. No further information is expected.
sour stomach; stated that she did not feel right; had stomach cramps on a medium pain scale; did not get much sleep; only ate 1/3 of meal/Stated ate less breakfast than usually does; This is a spontaneous report from a contactable consumer(patient). A 66-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 09Feb2021(at the age of 66-year-old) as dose 2, single for Covid-19 immunisation.The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 as dose 1, single for Covid-19 immunisation and stated had no problems with the first one. The patient had her second vaccine on 09Feb2021 (reported as yesterday). She had no problems with the first one. Stated that she got supper after the vaccine and about halfway through the meal noticed that she did not feel right and only ate 1/3 of meal. She tossed and turned all night did not get much sleep. The patient ate less breakfast than usually does. It was reported that with lunch she got sour stomach or stomach cramps medium scale pain. The patient wanted to know if there were any over the counter medication that she could take for her problems or if she should speak with her doctor about a prescription. On Feb2021, the patient experienced sour stomach and stated that she did not feel right, had stomach cramps on a medium pain scale, did not get much sleep, only ate 1/3 of meal/stated ate less breakfast than usually does. The patient underwent lab tests which included stomach cramps: medium on unknown date in Feb2021. Outcome of the events were unknown.  Follow-up attempts completed. No further information expected.
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age, unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 16-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 25-JUN-2021, the patient experienced confirmed immunological vaccine failure. Laboratory data included: COVID-19 antibody test (NR: not provided) No antibody. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210908154.; Sender's Comments: V0: 20210907883-covid-19 vaccine ad26.cov2.s -confirmed immunological vaccine failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Pt here today for vaccines, DTaP, IPV, MMR and should of been Varicella, but student gave ZOSTAVAX instead, pt at time of vaccine did not experience any adverse reaction.
Employee was given a 3rd MMR instead of a Varicella vaccine. No Adverse events noted.
EE had her shingles vaccine on 10-26-15. She states two days later she had red area at injection site that was firm and warm to touch. She indicated the size to be approx. 3-4 cm in diameter. She states she was too busy to report it at the time. The only symptom she has now is it is still a "little itchy" at time. No visual symptoms to report.
Red patch on arm approximately 2 inches beneath site of injection, warm and painful to the touch, oval in shape, approximately 4in by 2.5 in in size; Patient has applied ice and heat and taken Aleve for the pain;  Patient reports that it has not gotten worse or improved since she noticed it on 11/19/19.
This spontaneous report was received from a medical assistant concerning a 13-year-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 19-JAN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot number: L016429, expiration date: 09-AUG-2017, dose, dose number, anatomical location and route of administration were not provided). The vaccine underwent temperature excursion of either +1 or -1 degree Celsius for 255.5 total cumulative hours, which was detected by a data logger. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same reporter. Additional information is not expected as all the data was already obtained.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Aug2023 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure, managed. Concomitant medication(s) included: HYDROCHLOROTHIAZIDE, start date: 15Nov2022; ATORVASTATIN, start date: 19Jul2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Oct2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of Covid-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: The efficacy of a vaccine varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine product to the reported events drug ineffective and COVID-19 cannot be ruled out.
Pt treated for Kawasaki disease ?related to vaccine?  5/27/08 Reviewed hospital medical records of 1/29-1/31/2008. FINAL DX: Kawasaki disease Records reveal patient experienced fever, irritability, maculopapular erythematous rash & red eyes w/conjuntivitis, cracked & swollen lips, & strawberry tongue x 4 days.  Tx w/IVIG & high dose ASA.  Improved & was afebrile but had continued red eyes & slightly swollen tongue, cracked peeling lips, & faint rash at D/C to home on continued high dose ASA.
I have not had a period since i received my 2nd COVID  vaccine. I have regular monthly periods.  I was last seen my my GYN on May 20, 2021 and mentioned that i had not had a period since  COVID vaccine..  Still no period.  LMP 5/2/2021  2nd COVID  vaccine received on 5/7/2021.  1st vaccine dose on 4/3/2021. Periods have been regular all year: first day period each cycle1/1/ 2021, 1/21/2021, 2/14/2021, 3/12/2021.    As soon as I received the 1st dose of the COVID vaccine in April  my period was delayed and now with the second shot I still have not  had a period since  5/2/2021
10:58AM Pt complains of heart rate "going too fast." Pt denies chest pain, sob, dizziness or nausea. Vitals signs were obtained and pt was given water and juice.  Pt reports "I feel fine except for my heart rate going fast." Aid (EMS) was called and attended to pt. Pt was cleared by EMS  and was safe for pt to go home with her husband driving. Pt reported "I feel okay now." 11:15AM Pt reported a second time of feeling her heart rate "going fast again."  Pt denies chest pain, sob, dizziness or nausea. Aid was called and attended the pt. Pt remained alert and oriented, speech and gait at baseline. Pt skin warm and dry. Aid collected vital signs.  Aid advised pt to seek medical attention if symptoms re-occur. Pt reports "feeling better" and agrees to seek medical attention if previous symptoms return. Pt driven home by her husband.
09:20 - Verified patient name and DOB prior to start of appointment. Patient denied feeling unwell. Patient denied any allergies to latex, eggs, and/or vaccines. Patient was not pregnant. Patient denied any history of seizures, Guillan-Barre syndrome.  09:25 - Set up area to do appointment on kitchen table. Afluria seasonal flu shot administered to L deltoid.  09:25-09:40 - Stayed with patient per protocol. Denied any allergic reactions (shortness of breath, itchiness, redness, dizziness)  09:40 - Upon attempt to leave appointment, patient stated that he "felt short of breath." Patient walked towards kitchen counter from kitchen table (approximately 20-30 feet) and leaned on counter for 10 seconds. Patient appeared to be shaking. Patient fell back and hit L side of head and loss consciousness for approximately 15-30 seconds. Patient regained consciousness and was able to answer his name, date of birth, and verification of nurse.  Patient appeared to be diaphoretic and pale. Patient called his fiance to check up on him. Explained course of events to fiance. Notified her that I will be getting equipment in my car to check his vital signs and blood sugar.  09:50 - Checked patient's vital signs (BP 115/75, HR 64, O2 sat 99% on RA) and blood sugar (109mg/dL).  Educated patient regarding signs and symptoms to look out for including dizziness, shortness of breath, nausea, vomiting. Notified patient that a nurse from our clinical team will be contacting him around 2pm for a clinical check in.  10:58 - Left appointment. 14:33 - Clinical lead of the day had called patient to check on current status. Patient stated that he was feeling better than before.
Full-body rash that started 2 days subsequent to receiving the vaccine.  Rash was urticarial in nature.  Resolves with Benadryl.
AFTER VACCINATION DONOR HAD A HEADACHE AND WAS SWEATING. REACTION LASTED LESS THAN 10 MIN.
Developed hives on trunk about 24 hours after vaccination that improved after taking Benadryl. The following day (2nd day after screening) developed hives on face that again resolved with Benadryl. No respiratory issues
pt recvd vax; woke up next am w/ extremely stiff neck & lt shoulder pain;
The following day I had an extreme headache; it hurt to move. On the second day following the injection, I still had the headache but it diminished with each passing hour. In addition, on that second day following the injection I was incredibly weak which lasted into the third day following the injection. In fact, on the fourth day I still had some weakness and dizziness but was able to function.
I have had my platelets counted on several occasions. When I had my platelets counted in August 2019, they were 360,000, which is considered within normal range. However, the first time the platelet count was outside of normal range was in November 2019, and then it was 451,000. In January 2020, it was again within normal range at 417,000. In February 2021, it was at 425,000, which is also considered to be within normal range, However, in June 2022, my platelet count was at 494,000 which is well outside of normal range. In December 2022, it was 599,000. In January 2023, it was 571,000. Most recently, on 3/22/2023, it was at 565,000. I don't know if there is any correlation between my the COVID-19 vaccines and boosters, but prior to getting my elevated reading in June 2022, I received a booster on 4/27/2022. I have no discernable symptoms, but I am consulting a hematologist, who has informed that a genetic mutation, JAK 2V617F, was detected. I am due to see my hematologist again on 6/14/2023.
First dose - sore arm and bruising for 2 weeks Second dose - Fever, onset 24 hours after shot, lasted for 12 hours, maximum temperature 101.7 Second dose - Dizziness/vertigo, onset 48 hours after second dose with slight symptoms; severe symptoms  on morning of 3rd day after second dose, confined to bed.